We are delighted to welcome Lynne Berry OBE as the new Chair of the HTA.
Lynne will be in post from Monday 18 November 2019. Lynne joins us with a wide range of experience across the health and care system as a CEO and more recently, in non-executive director roles.
Lynne is Chair of Sustrans and is a trustee of The Welsh National Opera. She is also a Visiting Professor at Cass Business School (City, University of London), a Fellow Commoner of Lucy Cavendish College (University of Cambridge), and an Honorary Fellow of Cardiff University.
Until recently, Lynne was Chair of Breast Cancer Now and before that, Deputy-Chair of the Canal and River Trust, Chair of Glandŵr Cymru (The Canal and River Trust in Wales), and was a non-executive director and Senior Independent Director at Cambridge University Hospitals NHS Foundation Trust.
She has held Chief Executive roles at The Royal Volunteering Service (RVS), The Charity Commission, The General Social Care Council, The Equal Opportunities Commission, and The Family Welfare Association.
Lynne has a long interest in regulation, and together with her former roles in regulation, has been a member of numerous Government "better regulation" initiatives, and chaired a working group on risk and regulation for the Cabinet Office.
Our current interim Chair, Bill Horne, will continue in post until Monday 18 November.
Allan Marriott-Smith, Chief Executive of the HTA, said:
“Lynne’s wide-ranging passion and experience of the healthcare landscape will undoubtedly impart a unique insight and invaluable contribution to our regulation."
"We look forward to working with Lynne and honouring our commitment to patients and the public, and making sure that human tissue and organs are used safely, ethically and to a high quality."
"I would also like to take this opportunity to thank Bill who has been acting as Interim Chair since January, and who will continue to act in this position until Lynne assumes her role. We are of course delighted that our work with Bill will continue as he remains on our HTA Board.”
The Board of the HTA is referred to as “the Authority”, and Members of the Authority come from a range of backgrounds linked to our work, as well as lay Members who bring a wide range of other experience.
The Authority play a role in setting the strategic direction of the HTA, scrutinising it and holding it to account for its performance, which includes overseeing remuneration arrangements and acting as panel members for certain decisions on living organ donation.
You can read more about the HTA Authority and Executive Team on our website.
Lynne has been appointed as Chair of the Human Tissue Authority with effect from 18 November for 3 years. Her appointment will also involve a time commitment of 2-3 days per week and remuneration will be at a rate of £42,000 per annum.
This appointment is made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments.
The appointment is made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. Lynne has not declared any political activity.
Further details on DHSC non-executive appointments can be found on the Gov.UK website.
For more information, please contact the HTA Communications Team